Published November 10, 2025 | Version v1
Journal article Open

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction

Authors/Creators

Description

ABSTRACT

Dapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin.

Keyword- SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.

Files

AJPHR1310001.pdf

Files (708.3 kB)

Name Size Download all
md5:e817cb4610b4fe64a207fb79d26d11d0
708.3 kB Preview Download

Additional details

Identifiers

EISSN
2321-3647

Related works

Is published in
Journal article: 2321-3647 (EISSN)

Dates

Available
2025-10-10

References

  • AMERICAN JOURNAL OF PHARMACY AND HEALTH